NCT06641102

Brief Summary

This is a randomized clinical trial to evaluate a digital pain reprocessing therapy (PRT) intervention for chronic back pain (CBP). The purpose of this research is to test whether a new digital treatment for chronic pain works as well as traditional treatments for chronic back pain (CBP). Some people with CBP experienced side effects from other treatments, or previous treatments did not relieve pain, so this research aims to see if a digital therapy is a better option for CBP. This study will assess changes in pain intensity from PRT intervention compared to a standard of care (SOC) control group in adults with CBP. SOC is defined as a comprehensive clinical care plan, including a consultation with physiatrist and prescribed interventions, which will capture a comparison representative of all potential interventions that are recommended for an individual. The research team plans to enroll 180 participants who will be randomized into one of three groups.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

May 12, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

July 18, 2025

Status Verified

June 1, 2025

Enrollment Period

10 months

First QC Date

October 11, 2024

Last Update Submit

July 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Brief Pain Inventory Short Form

    A 9-item instrument with total score from 0 to 10, with higher score indicating worse outcomes. Full scale from 0 to 10, with higher score indicating more pain symptoms. Minimum score: 0 (no pain) Maximum score: 10 (pain as bad as you can imagine)

    <Day 0, Day 0, Day 1, Week 6, Week 10, Month 8.5

Study Arms (3)

Participants with Chronic Back Pain in Self-Guided Program

EXPERIMENTAL

Participants with CBP in a self-guided program that includes videos, guided meditations, and worksheets that are delivered to users in 10 different topical modules.

Other: Self-Guided Program (Tier 1)

Participants with Chronic Back Pain in Coach Assisted Program

EXPERIMENTAL

Participants with CBP in a one-on-one coaching program that sets users up with trained PRT coaches who will walk them through the program individually.

Other: Coach Assisted Program (Tier 3)

Participants receiving Standard of Care

ACTIVE COMPARATOR

Standard of care (SOC) control group in adults with CBP.

Other: Standard of Care (SOC)

Interventions

The study intervention is a smartphone application. Tier 1: self-guided program, includes videos, guided meditations, and worksheets that are delivered to users in 10 different topical modules. Two modules are delivered per week, with email reminders. It will emphasize that PRT is a practice that requires users to come back to the material regularly to help retrain the brain often (just like how you need to practice and complete exercises between PT sessions).

Participants with Chronic Back Pain in Self-Guided Program

The study intervention is a smartphone application. Tier 3: one-on-one coaching program that sets users up with trained PRT coaches who will walk them through the program individually. Users will meet with the assigned coaches once per week for an hour-long Zoom-hosted session that covers the same information as Tier 1, however in a completely personal and individualized way, focusing on the content that is most relevant for the user/patient at the time of the session. Tier 3 users will also receive materials from their coaches (e.g. videos, meditations, etc.) to support their own practice between session.

Participants with Chronic Back Pain in Coach Assisted Program

SOC is defined as a comprehensive clinical care plan, including a consultation with physiatrist and prescribed interventions, which will capture a comparison representative of all potential interventions that are recommended for an individual.

Participants receiving Standard of Care

Eligibility Criteria

Age21 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 21 to 70
  • Chronic Back Pain- CBP will be defined according to the criteria established by a recent NIH task force
  • Pain duration must be at least 3 months, with back pain being an ongoing problem for at least half the days of the last 6 months. That is, patients can meet criteria by either reporting pain every day for the past 3 months, or by reporting pain on half or more of the days for the past 6+ months.
  • Patients must rate pain intensity at 4/10 or greater on the Brief Pain Inventory-Short Form (BPISF) (on the item measuring average pain over the last week).
  • Participants must also be comfortable and able to communicate via email or text message, as several study measures are collected in this manner.
  • Able to use a smartphone

You may not qualify if:

  • Back pain associated with compensation or litigation issues as determined by self-report within the past year
  • Leg pain is greater than back pain, as this suggests neuropathic pain, which may be less responsive to psychotherapy
  • Cauda Equina syndrome, as screened for by self-reported inability to control bowel or bladder function
  • Self-reported diagnoses of schizophrenia, multiple personality disorder, or dissociative identity disorder
  • Self-reported use of intravenous drugs, due to concerns about infections and subject compliance with experimental protocols

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Icahn School of Medicine at Mount Sinai - Abilities Research Center

New York, New York, 10029, United States

RECRUITING

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • David Putrino, PhD

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The study team will remain unblinded for study procedures. Statistical analysis will be performed by a statistician who is blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 11, 2024

First Posted

October 15, 2024

Study Start

May 12, 2025

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

July 18, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

There is no plan to share IPD.

Locations